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This paper discusses the indications for
su rgery in mitral valve disease by comparing the
natural history of the disease, as it can best be
determined from the literature, with the results
of various surgical procedures. It may be stated
at the outset, however, that there are no controll ed studies comparing medical and surgical
treatment nor are they likely to be carried out in
the near future.

Mitral Stenosis
1. Detection . While the auscultatory findings of mitral stenosis are characteristic , many
patients go undetected by routine clinical examination; it is, therefore, important to be aware of
the special syndromes with which they may
present (Table 1).
Mitra! stenosis is much more common in
women and should be looked for particularly in
those who are young or middle-aged . The condition is predominantly a sequel to rheumatic
heart disease which is prevalent among large
famil ies from lower socioeconomic groups. The
availability of M-mode echocardiography in recent years has been of great help in the detection of mitral stenosis, since this procedure has
nearly 1 00% sensitivity and the specificity is almost as good . With the two-dimensional echocardiogram the degree of stenosis can be measured with great precision by mapping out the
valve area . Echocardiography has thus eliminated the need for cardiac catheterization either
for the detection or quantification of mitral stenosis, and cardiac catheterization is now emCorrespondence and reprint requests to Dr . Zubair ul
Hassan, McG uire VA Hospital, 1201 Broad Rock Road ,
Richmond, VA 232 49 .

ployed only preoperatively for the detection and
assessment of associated lesions.
2 . Natural history. Bland and .Jones in
their classical 20-year study of 1 ,000 patients
with acute rheumatic fever showed the extreme
variability in the rate of progression of mitral stenosis in different patients. 1 Some patients developed mitral stenosis within 5 years after the first
attack of rheumatic fever while others were relatively well even 50 years later; however, a composite average can be deduced from this and
other studies. In the preantibiotic era, mitral stenosis was clinically detectable approximately
1 0 years after the onset of acute rheumatic fever, symptoms were minimal in the next 10
years unless pregnancy or complications occurred (for example, endocarditis or atrial fibrillation), and in the next 20 years symptoms increased progressively with development of
pulmonary hypertension , heart failure , and systemic embolism , leading to death , approximately 40 years after the onset of rheumatic fever, at an average age of 48 (Fig 1). 1 - 3
It is my impression that mitral stenosis
today shows a slower rate of progression in the
industrialized countries, mainly because the use
of antibiotics has considerably improved the
rate of recurrence of rheumatic fever and the
treatment of endocarditis.
One of the most useful studies of the natural history of mitral stenosis is by Olesen and
Baden who classified their patients according to
the New York Heart Association (NYHA) classification and compared the non-surgical groups
seen during the years 1933-1 950 with the initial 1 65 consecutive patients operated on during the years 1950-1955 (Fig 2).4 Most studies
of surgical treatment of mitral stenosis have
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TABLE 1
Some Presenting Syndromes in Mitral Stenosis
EXERTIONAL DYSPNEA OR PULMONARY
EDEMA WITHOUT GENERALIZED CARDIOMEGALY
A TRIAL FIBRILLATION
SYSTEMIC EMBOLISM
(STROKE, MYOCARDIAL INFARCTION, HEMATURIA,
ETC.)
HEMOPTYSIS WITHOUT PULMONARY INFECTION
RESTRICTIVE AND OBSTRUCTIVE LUNG DISEASE
WITHOUT SMOKING HISTORY

used Olesen and Baden's non-surgical patients
for comparison . In NYHA Class II patients with
normal sinus rhythm the ten-year survival was
80%. At the other extreme over 50% of Class
IV patients were dead within five years and all
were dead within eight years.

3. Choice of operations and results . The
possibility of correcting the mechanical problem
of mitral stenosis surgically was first discussed
around the turn of the 20th century. The first attempts at surgical correction were made in the
1 920s, but mitral valvotomy has come to be
recognized as a generally acceptable method of
treatment only since 1948. Today several different surgical procedures are available for the
repair of mitral valve disease, some of the more
common being listed in Table 2.
The operative and postoperative morbidity
and mortality rates are very low for mitral commissurotomy but considerable when mitral valve
replacement with a prosthesis is necessary . It
is important, therefore, to determine preoperatively whether the patient with mitral stenosis will require commissurotomy or valve replacement. Table 3 gives some of the signs that
determine this decision. Successful mitral com-
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Fig 1-Natural progression of mitral stenosis. Clinical course, pathology and hemodynamic changes are correlated. Valve area
is indicated below each diagram of valve. CO = cardiac output; Exer = exercise; LA = left atrial pressure; N = normal; PA =
pulmonary arterial pressure;! = decreased; j = increased.
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Fig 2---Mitral Stenosis: Survival curves of surgery and medically treated patients. A. Normal sinus rhythm (NSR), NYHA Class II,
B. NSR, NYHA Class Ill; C. Atrial fibrillation and NYHA Class II or Ill; 0. NYHA Class IV. Vertical bars give 2 standard errors
above and below each point.

missurotomy is not possible if significant regurgitation accompanies stenosis or if the valve is
heavily scarred, markedly deformed, or calcified and immobile. Attempts at valvotomy in calcified valves result in fracture of the valve with
resu ltant insufficiency rather than cleavage of
the commissures. Lack of valve mobility is evident clinically by the absence of an opening
snap and the presence of a muffled first heart
sound; calcification can be detected by fluoroscopy and echocardiography. Repeated commissurotomies also cause extensive scarring
and deformity which necessitate valve replacement.
Olesen and Baden showed that 'closed'

TABLE 2
Common Operations Available for Mitral Valve
Disease

• COMMISSUROTOMY
CLOSED
OPEN
• VALVE REPAIR
ANNULOPLASTY
VAL VULOPLASTY
CARPENTIER RING
• VALVE REPLACEMENT
CAGE AND BALL VALVE
TILTING DISC VALVE
PORCINE TISSUE VALVE
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TABLE 3
Signs Indicating Probable Need for Valve
Replacement in Mitral Stenosis

•
•
•
•

INTENSITY OF S 1 OR OPENING SNAP REDUCED
SIGNIFICANT MITRAL INSUFFICIENCY
DENSE CALCIFICATION OF MITRAL VALVE
PRIOR MITRAL SURGERY

mitral commissurotomy (that is, commissurotomy without cardiopulmonary bypass or
'open'-heart surgery) improved survival in all but
minimally symptomatic patients in normal sinus
rhythm .4 Long-term survival was adversely affected by the presence of preoperative pulmonary hypertension or postoperative mitral insufficiency. Ellis, Harken and Black reported
essentially similar results in a much larger series
of 1 ,000 surgical cases. 5
In the United States, most institutions use
open mitral commissurotomy (that is, with cardiopulmonary bypass) as the procedure of
choice for mitral stenosis. The results of open
commissurotomy are probably superior to the
closed operation , although it is a more expensive procedure. Improvements in surgical
technique have markedly reduced the incidence
of systemic embolization and mitral insufficiency, which were the principal dangers of
mitral commissurotomy in earlier days. The
mortality from mitral commissurotomy today is
less than 1 % when the operation is done at an
optimal time and most survivors experience improvement in their symptoms.6
When mitral stenosis can be treated with
commissurotomy, the operation should be recommended as soon as symptoms interfere with
the normal enjoyment of life or at the earliest
signs of complications. In a substantial minority
of patients, the valve restenoses after several
years with recurrence of symptoms. Additional
surgery should be considered in these patients.
The other types of mitral valve surgery will
be discussed with the treatment of mitral insufficiency.

Mitral Regurgitation
The causes of mitral regurgitation are numerous; however, it is usually caused by congenital heart defects in young children, rheumatic heart disease or mitral valve prolapse in
young adults, and coronary artery disease in
older patients. The systolic apical murmur radiating into the axilla is usually easy to detect and
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is almost diagnostic of mitral regurgitation, although occasional patients with aortic stenosis
have their murmur referred to the mitral area.
Rupture of chordae tendineae to the posterior
mitral leaflet may produce a murmur loudest at
the sternum, simulating aortic stenosis. After
mitral valve replacement, significant mitral regurgitation may occur silently but should be suspected if left ventricular failure or hemolytic
anemia develops unexpectedly.
Detailed studies of the natural history of
mitral regurgitation according to severity of the
lesion or staging by symptoms are not available.
Some impressions can be drawn from the prospective study of rheumatic fever by Bland and
Jones. 1 The prognosis of asymptomatic, mild,
chronic mitral regurgitation without cardiomegaly is no different from that of the normal population ; however, when significant symptoms are
present with moderate-to-marked cardiomegaly, life expectancy is considerably shortened .
In Rapaport's experience approximately 20% of
the patients with mitral regurgitation were dead
within five years and 40% within ten years after
their initial diagnosis.3
Another consideration in mitral regurgitation regarding prognosis is the cause of the lesion. Most patients with mitral valve prolapse
(click-murmur, Barlow syndrome) have a
nonprogressive lesion. Mitra! regurgitation secondary to chronic left ventricular failure and dilatation (for example, cardiomyopathy, hypertension) usually does not respond well to surgical treatment. In contrast with chronic mitral insufficiency, acute mitral insufficiency is very
poorly tolerated and leads to rapid heart failure.
Acute mitral regurgitation usually results from
rupture of papillary muscles, chordae tendineae
or valve leaflets due to infarction, infection or
trauma, and occasionally spontaneously. In
acute cases more attention should be paid to
the severity of the hemodynamic lesion, as determined by physical signs and cardiac catheterization , than to the symptoms.
The combined lesion of mitral stenosis
and regurgitation is usually due to rheumatic
heart disease and is treated like mitral regurgitation because most patients require mitral valve
replacement.

Mitral Valve Repair
The concept of repairing the valve instead
of replacing it with a prosthesis is extremely at-

tractive, particularly for younger patients. 7 - 9 It
avoids the problems of thromboembolism, infection and hemolysis consequent upon the introduction of a foreign body into the bloodstream . The proponents of valve repair claim
that it is feasible in a majority of patients with mitral regurgitation, but others have largely
avoided it. Several different techniques have
been described. Annuloplasty reduces the size
of the valve orifice by plication of the annulus
fusing the peripheral portions of the mitral commissures . Complete obliteration of mitral insufficiency is frequently not possible by this
technique and postoperative dilatation of the
mitral annulus may necessitate valve replacement at a later date. Valvuloplasty is a spectacularly successful and curative operation for
many cases of ruptured chordae tendineae. The
redundant untethered portion of the posterior
leaflet is obliterated by pleating with sutures.
The Carpentier ring is a slightly irregular biarcuate stainless steel ring wrapped in a teflon
collar for sewing which has been recently introduced as an aid to valvuloplasty. The ring
prevents further dilation of the valve, and the
sewing collar is used to anchor the sutures and

A

8

remold the deformed valves to approximate normal anatomy. Risk of thromboembolism and
endocarditis is not significantly increased with
the use of the Carpentier ring . At present, valve
repair should be strongly considered in younger
patients and in those with mitral insufficiency
secondary to rupture of the posterior leaflet
chordae tendineae. With continuing improvements in technique, valve repair is likely to become possible in a larger proportion of patients.
The risk of valve repair is minimal, and marked
symptomatic improvement occurs after successful surgery, but it is not possible to decide
preoperatively whether repair or valve replacement will be necessary in a specific patient. The
indications for valve repair are therefore the
same as for valve replacement as discussed below.

Mitral Valve Prostheses
Three main types of prostheses are currently in use (Fig 3). Various models of the StarrEdward heart valves are examples of the cageball type of prosthesis. Blood flows turbulently
around the occluding ball in contrast to the laminated flow in the normal valve. Long experience

c

Fig 3- Three commonly used mitral valve prostheses. A. Starr-Edward Model 6120; B. Bjork-Shiley; C. SGP Hancock Porcine
Model 342 .
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with these valves has shown them to be durable
and reliable. The main problem is thromboembolism which is reduced but not eliminated by
anticoagulants. Traumatic hemolysis may occur
in models of the valve with cloth-covered struts.
Another problem is the very loud closing click
with some models. This sound can occasionally
be heard by the unaided ear across the room
from the patient. The incidence of infection of
the prosthesis is probably similar to the other
prosthetic valves.
Tilting disc valves, such as the BjorkShiley, have a more physiological blood flow
and a low profile so that the valve does not occlude the left ventricular cavity. The major advantage of this valve is that the sewing ring is
not disproportionately larger than the internal lumen and these valves are therefore associated
with the lowest transvalvar gradients among all
prosthetic heart valves . However, anticoagulation is needed and the closing click can
be quite noisy. This is the prosthetic valve of
choice in patients with a small mitral valve annulus.
Glutaraldehyde-treated porcine heterografts are becoming increasingly popular because of low thrombogenicity even without anticoagulation. These valves consist of porcine
aortic valve tissue mounted on a man-made
frame. Flow is central, very much as in the normal valve, but the sewing ring is considerably
larger than the internal lumen, and large transvalvar gradients may be present postoperatively, particularly with the smaller-sized
sewing rings. Long-term durability is another
major concern . Nevertheless, this is the prosthesis of choice when anticoagulation is contraindicated .
Characteristics of the three valves discussed above are compared in Table 4.
Results of valve replacement. Comparative studies of different types of valve prostheses are not available at present. It appears,
however, that the operative mortality for the different types of prostheses mentioned above is
roughly comparable, and the risk factors for operative mortality and long-term results are also
similar. The most important risk factors for early
operative mortality are advanced heart failure
and marked cardiomegaly, particularly left atrial
enlargement (Fig 4 ). 6 · 10 The long-term results
are adversely affec!ed in patients with marked
left atrial enlargement or pulmonary hyper-
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TABLE 4
Comparison of Three Most Commonly Used Prosthetic
Heart Valves. Pros and Cons Graded from One to
Three Plus. S-E = Starr-Edward; B-S = Bjork-Shiley;
P-H = Porcine Hancock.
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tension . Most survivors of the operation show
symptomatic improvement, but their survival
curve does not parallel that of the general population (Fig 5). Young patients with severe mitral
regurgitation show a remarkable reduction in
cardiac size following successful surgery,
whether valve repair or valve replacement. Mitral valve replacement is recommended in all
patients with significant symptoms, that is,
NYHA Class Ill or IV. It is also indicated in acute
severe mitral regurgitation and significant mitral
regurgitation with progressive cardiomegaly or
pulmonary hypertension, even when symptoms
are less impressive (Table 5). It is advisable not
to wait until advanced stages of heart failure,
cardiac enlargement, or pulmonary vascular
changes occur, but unfortunately patients are
all too frequently in this condition when they first
seek, or are referred for, valve surgery.
In summary, the natural history of mitral
valve disease is discussed and compared with
various surgical procedures. Life expectancy is
considerably shortened when mitral stenosis is
accompanied by significant symptoms or complications. Mitral commissurotomy is a relatively
benign procedure (< 1 % mortality) which improves survival and symptoms in these patients.
Chronic mild mitral regurgitation is tolerated
well, but progressive cardiac dysfunction occurs
when regurgitation is severe, particularly if it develops acutely. Valve repair can be performed
in some cases with a low mortality and very low
postoperative morbidity. Most patients with incompetent valves require valve replacement in
which the average surgical mortality is approxi-
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TABLE 5
Indications for Valve Replacement in Mitral
Regurgitation
NYHA CLASS Ill OR IV
SIGNIFICANT ENLARGEMENT OF LEFT ATRIUM OR
VENTRICLE
PULMONARY HYPERTENSION
ACUTE SEVERE MITRAL REGURGITATION

mately 5%; thromboembolism is the most serious postoperative problem .
Surgical mortality is markedly increased in
advanced heart disease (NYHA Class IV) and
surgical treatment should therefore be considered in all patients with mitral valve disease before this stage is reached.
Figure 1 is taken in part from Proceedings of the Royal
Society of Medicine (60: 1 009-1 01 5, 1 96 7) and the
American Journal of Cardiology (35:221-227, 1975) by
permission.
Figure 2 is adapted from the Scandinavian Journal of
Thoracic and Cardiovascular Surgery (3:119-124, 1969)
by permission.
Figure 4 adapts data found in Barnhorst et al , American Journal of Cardiology (35 :228-233, 1975).
Figure 5 is adapted from the American Journal of Cardiology (35 :22 8-233, 1975) by permission .
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